SIRPB1 promotes prostate cancer cell proliferation via Akt activation.
- Published in:
- Prostate, 2020, v. 80, n. 4, p. 352, doi. 10.1002/pros.23950
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2020 AND VI 80 AND IP 4
Results: 7
1
2
Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high‐risk prostate cancer: Histopathological and molecular analyses.
- Published in:
- Prostate, 2020, v. 80, n. 4, p. 345, doi. 10.1002/pros.23949
- By:
- Publication type:
- Article
3
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy.
- Published in:
- Prostate, 2020, v. 80, n. 4, p. 336, doi. 10.1002/pros.23948
- By:
- Publication type:
- Article
4
Overall, specific, and metastasis‐free survival of Afro‐Caribbean men with pathological Gleason 6 prostate cancer.
- Published in:
- Prostate, 2020, v. 80, n. 4, p. 329, doi. 10.1002/pros.23947
- By:
- Publication type:
- Article
5
A novel androgen receptor antagonist JJ‐450 inhibits enzalutamide‐resistant mutant AR<sup>F876L</sup> nuclear import and function.
- Published in:
- Prostate, 2020, v. 80, n. 4, p. 319, doi. 10.1002/pros.23945
- By:
- Publication type:
- Article
6
Ascleposide, a natural cardenolide, induces anticancer signaling in human castration‐resistant prostatic cancer through Na<sup>+</sup>/K<sup>+</sup>‐ATPase internalization and tubulin acetylation.
- Published in:
- Prostate, 2020, v. 80, n. 4, p. 305, doi. 10.1002/pros.23944
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Prostate, 2020, v. 80, n. 4, p. 303, doi. 10.1002/pros.23848
- Publication type:
- Article